Portfolio expanded

09.11.2011 10:41

Springer acquires Pharma Marketing and Publishing Services from Wolters Kluwer

Springer Science+Business Media (www.springer.com) has reached an agreement with Wolters Kluwer to purchase Pharma Marketing and Publishing Services (MPS) for the Springer Healthcare division. MPS is one of the world's five largest providers of strategic marketing, publishing and business intelligence products and services for the pharmaceutical industry as well as for medical libraries, academic institutions and research institutes. MPS includes the Adis journal portfolio with 24 highly respected scientific journals and newsletters for pharmacology and drug therapy. MPS also offers, among other things, databases for drug development and drug safety, market analyses, strategic medical marketing and communication, information material for prescribers or patients and training for pharmaceutical field sales. MPS employs around 450 people. The main offices are in Auckland (New Zealand), Chester (UK), Yardley, PA (USA) and Milan (Italy).

Derk Haank, CEO of Springer Science+Business Media, commented on the purchase as follows: “This acquisition will significantly strengthen our position in the international corporate and healthcare markets and also allows us to expand Springer's STM activities not only in the Americas and Asia-Pacific - area, but also in the parts of Europe where we do not yet have branches. MPS’ high-quality content and services for corporate and university customers are an excellent addition to Springer’s existing portfolio.” Peter Coebergh, President of Corporate and Healthcare Markets at Springer, sees the purchase as an “opportunity for Springer and MPS to work together to develop new and valuable ideas for our customers.” The merger of the product ranges of MPS and Springer Healthcare is only the first step on this path.